Source:http://linkedlifedata.com/resource/pubmed/id/19602726
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
37
|
pubmed:dateCreated |
2009-9-7
|
pubmed:abstractText |
CD4(+)CD25(+) regulatory T cells (T regs) play a major role in the maintenance of self-tolerance and immune suppression, although the mechanisms controlling T reg development and suppressor function remain incompletely understood. Herein, we provide evidence that Kruppel-like factor 10 (KLF10/TIEG1) constitutes an important regulator of T regulatory cell suppressor function and CD4(+)CD25(-) T cell activation through distinct mechanisms involving transforming growth factor (TGF)-beta1 and Foxp3. KLF10 overexpressing CD4(+)CD25(-) T cells induced both TGF-beta1 and Foxp3 expression, an effect associated with reduced T-Bet (Th1 marker) and Gata3 (Th2 marker) mRNA expression. Consistently, KLF10(-/-) CD4(+)CD25(-) T cells have enhanced differentiation along both Th1 and Th2 pathways and elaborate higher levels of Th1 and Th2 cytokines. Furthermore, KLF10(-/-) CD4(+)CD25(-) T cell effectors cannot be appropriately suppressed by wild-type T regs. Surprisingly, KLF10(-/-) T reg cells have reduced suppressor function, independent of Foxp3 expression, with decreased expression and elaboration of TGF-beta1, an effect completely rescued by exogenous treatment with TGF-beta1. Mechanistic studies demonstrate that in response to TGF-beta1, KLF10 can transactivate both TGF-beta1 and Foxp3 promoters, implicating KLF10 in a positive feedback loop that may promote cell-intrinsic control of T cell activation. Finally, KLF10(-/-) CD4(+)CD25(-) T cells promoted atherosclerosis by approximately 2-fold in ApoE(-/-)/scid/scid mice with increased leukocyte accumulation and peripheral pro-inflammatory cytokines. Thus, KLF10 is a critical regulator in the transcriptional network controlling TGF-beta1 in both CD4(+)CD25(-) T cells and T regs and plays an important role in regulating atherosclerotic lesion formation in mice.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/DE14036,
http://linkedlifedata.com/resource/pubmed/grant/F32HL086157,
http://linkedlifedata.com/resource/pubmed/grant/F32HL088819,
http://linkedlifedata.com/resource/pubmed/grant/HL080174,
http://linkedlifedata.com/resource/pubmed/grant/HL091076,
http://linkedlifedata.com/resource/pubmed/grant/R01 DE014036-09
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2 Receptor alpha Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Tieg1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1083-351X
|
pubmed:author |
pubmed-author:ApostolouIrinaI,
pubmed-author:CaoZhuoxiaoZ,
pubmed-author:EsenFehimF,
pubmed-author:FeinbergMark WMW,
pubmed-author:HanssonGöran KGK,
pubmed-author:IcliBasakB,
pubmed-author:KretschmerKarstenK,
pubmed-author:LibbyPeterP,
pubmed-author:PackardRené R SRR,
pubmed-author:SpelsbergThomas CTC,
pubmed-author:StapletonChristopher JCJ,
pubmed-author:SubramaniamMalayannanM,
pubmed-author:SunXinghuiX,
pubmed-author:WaraAkm KhyrulAK,
pubmed-author:von BoehmerHaraldH
|
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
24914-24
|
pubmed:dateRevised |
2011-4-28
|
pubmed:meshHeading |
pubmed-meshheading:19602726-Animals,
pubmed-meshheading:19602726-Atherosclerosis,
pubmed-meshheading:19602726-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19602726-Cell Separation,
pubmed-meshheading:19602726-Cytokines,
pubmed-meshheading:19602726-DNA-Binding Proteins,
pubmed-meshheading:19602726-Flow Cytometry,
pubmed-meshheading:19602726-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:19602726-Mice,
pubmed-meshheading:19602726-Mice, Transgenic,
pubmed-meshheading:19602726-Models, Biological,
pubmed-meshheading:19602726-RNA, Small Interfering,
pubmed-meshheading:19602726-T-Lymphocytes, Regulatory,
pubmed-meshheading:19602726-Transcription Factors,
pubmed-meshheading:19602726-Transforming Growth Factor beta1
|
pubmed:year |
2009
|
pubmed:articleTitle |
Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells.
|
pubmed:affiliation |
Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|